Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002013 · ClinicalTrials.gov registry record · NA
A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients
A NA study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002013: Completed NA study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
NCT00002013 is a NA study that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002013, a NA study, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate safety, pharmacokinetics, immunologic parameters and neurocognitive data for three dosages of AS-101 in combination with zidovudine (AZT) in patients with AIDS or AIDS related complex (ARC).
Interventions
- DRUG Zidovudine
- DRUG AS-101
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002013 record still lists
NCT00002013 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Zidovudine is the first listed.
NCT00002013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002013 about?
NCT00002013 is a clinical study titled "A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients". To evaluate safety, pharmacokinetics, immunologic parameters and neurocognitive data for three dosages of AS-101 in combination with zidovudine (AZT) in patients with AIDS or AIDS related complex (ARC).
What is the current status of trial NCT00002013?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002013?
The interventions under investigation include: Zidovudine (DRUG), AS-101 (DRUG).
Who is sponsoring clinical trial NCT00002013?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.